Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.00    -3.20 (-3.10%)
Bid:
100.40
Ask:
102.00
Spread: 1.60 (1.594%)
Market Cap: £163.94m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

8 Nov 2012 07:00

RNS Number : 6049Q
Yule Catto & Co PLC
08 November 2012
 



YULE CATTO & CO PLC

 

INTERIM MANAGEMENT STATEMENT

 

Continued resilient performance; Intention to change Group name

 

Yule Catto & Co plc ("Yule Catto" or "the Group") today issues its interim management statement for the period 1 July to 8 November 2012. The Group also announces its intention to change its name to Synthomer plc.

 

Trading

 

The Group has continued to perform in line with the Board's expectations since the last update provided at the interim results in August, despite the challenging macro-economic conditions, particularly in Europe.

 

In Europe and North America, profit to date remains well ahead of prior year. This has been achieved notwithstanding year to date volumes down 10%, and an adverse translation impact of £4.5 million in the first nine months of the year due to the weaker euro. This performance reflects the continued benefits of good margin management and synergy delivery which the Group has achieved during the period. Demand remains subdued with construction related areas continuing to be particularly affected. 

 

In Asia and ROW, the non-nitrile businesses continued the positive momentum achieved in the first half. Our Nitrile business is trading in line with the guidance provided at the interim results.

 

We continue to make strong progress with synergy delivery from the PolymerLatex acquisition, and remain firmly on track to realise £19 million of synergies in the current year, a year on year improvement of £16 million. The Group continues to expect to deliver the total £25 million of targeted annual synergies by March 2013. 

 

The Group's financial position remains robust with net debt at the end of September at £160 million, down from £174 million at the half year.

 

Outlook

 

The Board's expectations remain unchanged from those stated at the half year. Full year underlying profit before tax is expected to be ahead of 2011 pro-forma of £96 million.

 

Intention to change Group name to Synthomer plc

 

Over the last 5 years the Group has been transformed from a small, diversified chemical business, of which Yule Catto was the holding company, to a much larger, focussed speciality polymer business. The Group trades under the name Synthomer across the majority of its business, and the Board has therefore decided that now is an appropriate time to reflect this in the Group's name.

 

The Group will convene an Extraordinary General Meeting in on December 4 where shareholders will be asked to approve this change. If shareholders agree to this proposal, the Group's name will be changed to Synthomer plc before the year end. A circular to this effect will be distributed to shareholders today.

 

Commenting Adrian Whitfield, Group Chief Executive, said:

 

"We are pleased to have delivered a resilient performance in difficult market conditions. The Group's strong portfolio of products and leading market positions provide an excellent platform for growth and we remain confident of continuing to deliver value for our shareholders."

 

Enquiries:

 

Adrian Whitfield, Group Chief Executive

Charles Armitstead / Rosie Oddy

David Blackwood, Group Finance Director

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

 

The company will host a conference call for analysts at 8.00am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFFALLLDIIF
Date   Source Headline
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update
18th Dec 20147:00 amRNSBoard Changes
18th Nov 20147:00 amRNSAppointment of Group Chief Executive
28th Oct 20147:00 amRNSInterim Management Statement
22nd Oct 20143:00 pmRNSAcquisition
17th Oct 20141:03 pmRNSDirector/PDMR Shareholding
16th Oct 20143:56 pmRNSDirector/PDMR Shareholding
15th Oct 201412:35 pmRNSDirector/PDMR Shareholding
14th Oct 20142:40 pmRNSDirector/PDMR Shareholding
13th Oct 20149:35 amRNSDirector Declaration
11th Aug 20147:00 amRNSInterim Results
11th Jul 20147:00 amRNSTrading update
1st Jul 20147:00 amRNSAdrian Whitfield to step down as CEO
23rd Jun 201412:01 pmRNSHolding(s) in Company
30th May 20149:24 amRNSHolding(s) in Company
15th May 20144:26 pmRNSDirector/PDMR Shareholding
8th May 201411:25 amRNSDirector/PDMR Shareholding
7th May 20144:35 pmRNSDirector/PDMR Shareholding
1st May 20142:47 pmRNSResult of AGM
1st May 20147:00 amRNSInterim Management Statement
14th Apr 20149:23 amRNSHolding(s) in Company
9th Apr 20143:08 pmRNSHolding(s) in Company
9th Apr 201411:26 amRNSHolding(s) in Company
31st Mar 20149:40 amRNSAnnual Financial Report
14th Mar 20144:17 pmRNSHolding(s) in Company
14th Mar 201411:48 amRNSHolding(s) in Company
12th Mar 20142:40 pmRNSDirector/PDMR Shareholding
6th Mar 20144:15 pmRNSDirector/PDMR Shareholding
6th Mar 20144:12 pmRNSDirector/PDMR Shareholding
5th Mar 20147:00 amRNSChanges to Board Committees
4th Mar 20142:14 pmRNSHolding(s) in Company
28th Feb 20147:01 amRNSPreliminary Results
13th Feb 20142:57 pmRNSHolding(s) in Company
16th Jan 20148:53 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSDirectorate Change
6th Dec 20139:34 amRNSHolding(s) in Company
22nd Nov 20134:08 pmRNSHolding(s) in Company
20th Nov 201311:45 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSCapital Markets Day
12th Nov 20135:06 pmRNSHolding(s) in Company
8th Nov 20133:03 pmRNSHolding(s) in Company
7th Nov 20137:00 amRNSInterim Management Statement
29th Oct 20131:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.